| H3200706F | 
						Econazole | 
						Drugs, Metabolites Optical isomers | 
						Econazole | 
						CHIRAL ART Cellulose-SZ | 
						KSZ99S05-1546WT | 
					
									
						| R101005O | 
						Butenafine hydrochloride | 
						Drugs, Metabolites | 
						Butenafine hydrochloride | 
						YMC-Triart C18 | 
						TA12S03-1503WT | 
					
									
						| R100830A | 
						Butenafine hydrochloride solution and spray and cream | 
						Drugs, Metabolites | 
						Diphenyl (I.S.) 
Butenafine hydrochloride | 
						YMC-Pack Pro C8 | 
						OS12S03-0503WT | 
					
									
						| A110708A | 
						Terbinafine hydrochloride | 
						Drugs, Metabolites | 
						Terbinafine hydrochloride | 
						YMC-Pack Pro C18 RS | 
						RS08S05-1503WT | 
					
									
						| A110721C | 
						Terbinafine hydrochloride solution、spray and cream | 
						Drugs, Metabolites | 
						p-Terphenyl 
Terbinafine hydrochloride | 
						YMC-Pack ODS-A | 
						AA30S05-R504WT | 
					
									
						| V121023A | 
						Levocarnitine injection(L-Carnitine injection) | 
						Drugs, Metabolites | 
						Levocarnitine chloride(L-Carnitine chloride) 
Levocarnitine impurity A | 
						YMC-Triart Diol-HILIC | 
						TDH12S05-1546WT | 
					
									
						| F000629A | 
						Carnitine chloride | 
						Drugs, Metabolites | 
						Carnitine chloride 
L-Histidine hydrochloride | 
						Hydrosphere C18 | 
						HS12S05-1546WT | 
					
									
						| F000817A | 
						Catecholamines | 
						Drugs, Metabolites | 
						Norepinephrine hydrochloride 
Epinephrine 
3,4-Dihydroxyphenylalanine (DOPA) 
Dopamine hydrochloride 
4-Hydroxy-3-methoxymandelic acid 
3-Methoxytyramine hydrochloride 
4-Hydroxy-3-methoxyphenylglycol 
3,4-Dihydroxyphenylacetic acid 
Homovanillic acid | 
						Hydrosphere C18 | 
						HS12S05-1546WT | 
					
									
						| F130425D | 
						Simultaneous analysis of catecholamines,serotonin, and their precursors and metabolites  | 
						Drugs, Metabolites | 
						Noradrenaline hydrochloride (NA) (Norepinephrine hydrochloride) 
3,4-Dihydroxymandelic acid (DOMA) 
3,4-Dihydroxyphenylalanine (DOPA) 
Tyrosine (Tyr) 
Adrenaline hydrochloride (A) (Epinephrine hydrochloride) 
Dopamine hydrochloride (DA) 
Vanillylmandelic acid (VMA) 
3-Methoxy-4-hydroxyphenylglycol (MHPG) 
3,4-Dihydroxyphenylacetic acid (DOPAC) 
3-Methoxytyramine hydrochloride (3MT) 
Serotonin hydrochloride (5-Hydroxytryptamine hydrochloride,5-HT) 
Tryptophan (Typ) 
5-Hydroxyindoleacetic acid (5HIAA) 
Homovanillic acid (HVA) | 
						YMC-Triart PFP | 
						TPF12S03-1503WT | 
					
									
						| F070906B | 
						Xanthine oxidase inhibitor and its metabolites - method transfer to ultra-fast LC | 
						Drugs, Metabolites | 
						Uric acid 
Hypoxanthine 
Xanthine 
Oxipurinol 
Allopurinol | 
						YMC-UltraHT Hydrosphere C18 | 
						HS12S02-0502WT | 
					
									
						| F070906B | 
						Xanthine oxidase inhibitor and its metabolites - method transfer to ultra-fast LC | 
						Drugs, Metabolites | 
						Uric acid 
Hypoxanthine 
Xanthine 
Oxipurinol 
Allopurinol | 
						Hydrosphere C18 | 
						HS12S05-1546WT | 
					
									
						| F070906A | 
						Xanthine oxidase inhibitor and its metabolites in human serum | 
						Drugs, Metabolites | 
						Uric acid 
Hypoxanthine 
Xanthine 
Oxipurinol 
Allopurinol | 
						YMC-UltraHT Hydrosphere C18 | 
						HS12S02-0502WT | 
					
									
						| S930728J | 
						Xanthine oxidase inhibitor and related compounds | 
						Drugs, Metabolites | 
						Uric acid 
Hypoxanthine 
Xanthine 
Oxipurinol 
Allopurinol | 
						J'sphere ODS-M80 | 
						JM08S04-1546WT | 
					
									
						| S930729B | 
						Xanthine oxidase inhibitor and related compounds | 
						Drugs, Metabolites | 
						Uric acid 
Hypoxanthine 
Xanthine 
Oxipurinol 
Allopurinol | 
						J'sphere ODS-L80 | 
						JL08S04-1546WT | 
					
									
						| E211026A | 
						8-OHdG, an oxidative stress marker and related compounds | 
						Drugs, Metabolites | 
						7-Methylguanine (m7Gua) 
8-Hydroxy-2’-deoxyguanosine (8-OHdG) 
(-)-Nicotine 
(-)-Cotinine 
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)  | 
						YMC-Triart C18 | 
						TA12SP9-05Q1PT | 
					
									
						| E211130A | 
						8-OHdG, an oxidative stress marker and related compounds | 
						Drugs, Metabolites | 
						4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)  
(-)-Cotinine 
(-)-Nicotine 
7-Methylguanine (m7Gua) 
8-Hydroxy-2’-deoxyguanosine (8-OHdG) | 
						YMC-Triart Diol-HILIC | 
						TDH12SP9-10Q1PT | 
					
									
						| F041213A | 
						Caffeine metabolites | 
						Drugs, Metabolites | 
						Caffeine(1,3-TMX) 
Theophylline(1,3-DMX) 
Paraxanthine(1,7-DMX) 
Theobromine(3,7-DMX) 
1-Methylxantine(1-MX) 
1,7-Dimethyluric acid(1,7-DMU) 
1,9-Dimethyluric acid(1,9-DMU) (l.S.) 
 5-Acetylamino-6-amino-3-methyluracil(AAMU) 
1-methyluric acid(1-MU) | 
						YMC-Pack Polyamine II | 
						PB12S05-2546WT | 
					
									
						| F041213B | 
						Caffeine metabolites in human urine | 
						Drugs, Metabolites | 
						Caffeine(1,3-TMX) 
Theophylline(1,3-DMX) 
Paraxanthine(1,7-DMX) 
Theobromine(3,7-DMX) 
1-Methylxantine(1-MX) 
1,7-Dimethyluric acid(1,7-DMU) 
1,9-Dimethyluric acid(1,9-DMU) (l.S.) 
 5-Acetylamino-6-amino-3-methyluracil(AAMU) 
1-methyluric acid(1-MU) | 
						YMC-Pack Polyamine II | 
						PB12S05-2546WT | 
					
									
						| G910607G | 
						Purine catabolites | 
						Drugs, Metabolites | 
						Allantoin 
Allantoic acid 
Uric acid | 
						YMC-Pack ODS-AM | 
						AM12S05-1506WT | 
					
									
						| G910618A | 
						Purine catabolites | 
						Drugs, Metabolites | 
						Allantoin 
Allantoic acid 
Uric acid | 
						YMC-Pack ODS-AQ | 
						AQ12S05-1506WT |